Stock screener

VIR

Conviction 84HealthcareScan · Thu, Sep 24, 2026

Vir Biotechnology, Inc. (VIR) closed at $10.72 (-3.34%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 51, RS Rating 94, -7.8% from its 52-week high, +80.5% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

VIR$10.72-3.34%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 2.31M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Vir Biotechnology, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.vir.bio ↗
Price10.72
Change-3.34%
Gap-0.18%
Rel volume1.57×
Avg volume2.36M
Avg $ vol25.87M
SMA 2010.98
SMA 509.95
SMA 2008.89
Price vs 50+7.74%
Price vs 200+20.52%
MA stackbullish
50/200 cross—
Supertrendup · 9.78
RSI (14)51
MACD hist-0.05
MACD cross—
Stoch %K / %D33 / 55
ADX (14)21
+DI / −DI25 / 21
RSI divergence—
MACD divergence—
ATR %5.31%
ADR %4.96%
52w high11.63
52w low5.12
From 52w high-7.82%
Above 52w low+109.38%
New 52w highNo
SqueezeOff
Bollinger width13.20%
%B0.32
Donchian pos28.65%
Donchian high11.94
Donchian low10.23
AVWAP (52w high)10.91
vs AVWAP high-1.78%
AVWAP (52w low)8.84
vs AVWAP low+21.26%
OBV trendDown
Chaikin MF (20)-0.08
Today vs 20d1.57×
Avg vol (14d)2.31M
Avg vol (20d)2.36M
Avg $ vol (20d)25.87M
Market cap1.81B
RS Rating94 / 99
RS 3m (vs SPY)+4.01%
RS 6m (vs SPY)+2.43%
RS line new highNo
Trend template8/8
Technical rank77.7
1 week-1.83%
1 month+0.09%
3 months+8.50%
6 months+19.24%
1 year+107.35%
YTD+80.47%
P/E-4.14
P/B1.85
P/S26.46
P/FCF-4.57
EPS-3.16
Div yield—
ROE-44.58%
ROA-36.05%
Debt/Eq—
Current6.04
EV/EBITDA-3.28
Gross margin—
Net margin-638.87%
Rev growth-7.61%
EPS growth16.09%
Price target21.29
Target upside98.60%
Analyst ratingBuy
Institutional94.80%
Ent. value1.54B
Revenue240K
Net income80.08M
Gross profit—
Free cash flow-396.61M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out168.65M
Employees367
ListedFri, Oct 11, 2019
Free float95.89M
Float %68.7%
Short interest21.34M
Days to cover11.1d
Short volume67.2%
Squeeze score92 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.47 vs $0.83
Last surprise-43.4% miss
Setup gradeA
Conviction84 / 100
Pattern quality—
Tech rank77.7 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance11.83
Support8.71
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in VIR

All disclosures →
No recent disclosed trades by Congress in VIR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VIR · open-market 2 sells

InsiderSideShares
MORE ROBERT J
Director · Common Stock · 2026-08-11
Dispose8K
MORE ROBERT J
Director · Common Stock · 2026-08-11
Acquire8K
Coughlin Timothy
Director · Stock Option (Right to Buy) · 2026-06-09
Grant16K
Coughlin Timothy
Director · Common Stock · 2026-06-09
Grant8K
Sabatini Brent
SVP, Chief Accounting Officer · Common Stock · 2026-06-01
Sell379
Napolitano Janet
Director · Common Stock · 2026-06-01
Sell3.2K
Napolitano Janet
Director · Common Stock · 2026-05-27
Grant8K
BISCHOFBERGER NORBERT W
Director · Stock Option (Right to Buy) · 2026-05-27
Grant16K
MORE ROBERT J
Director · Stock Option (Right to Buy) · 2026-05-27
Grant16K
MORE ROBERT J
Director · Common Stock · 2026-05-27
Grant8K

SEC filings

EDGAR filings in VIR · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.